Diroximal fumarate - Multiple sclerosis
You are here : Home > Formulary Search > Diroximal fumarate - Multiple sclerosis
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Diroximal fumarate
Indication :
Multiple sclerosis
Group Name :
Keywords :
relapsing-remitting, NICE TA794
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Other Indications
Below are listed other indications that Diroximal fumarate is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Multiple sclerosis.
- Alemtuzumab
- Biotin
- Cladribine
- Dimethyl fumarate
- Donepezil hydrochloride
- Fampridine
- Fingolimod
- Galantamine
- Glatiramer acetate
- Interferon beta
- Memantine hydrochloride
- Modafinil
- Naltrexone hydrochloride
- Natalizumab
- Ocrelizumab
- Ofatumumab
- Ozanimod
- Peginterferon beta-1a
- Ponesimod
- Rivastigmine
- Siponimod
- Teriflunomide
Committee Recommendations (1)
This drug has been included on the joint formulary having been agreed by the DTC of at least one Surrey Heartlands Acute Trust.
See “Formulary Status” to identify where this drug has been agreed for use.